Morgan Stanley Upgrades West Pharmaceutical (WST) to Overweight
Morgan Stanley analyst Kallum Titchmarsh upgraded West Pharmaceutical (NYSE: WST) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

